US › Healthcare

Seer Inc (SEER)

US · Healthcare · Biotechnology

$2.21-1.34%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$2.7M
Revenue YoY
-34.7%
Net profit
$-16.8M
Profit YoY
+15.6%
EPS
$-0.30
EPS estimate
$-0.29
Net margin
-622.2%

EPS came in at -0.30 against a street estimate of -0.29 — a miss of 3.4%.

Key statistics

Market cap
$122.1M
Forward P/E
0.0
P/B
0.50
Book value
$4.38
EPS (TTM)
$-1.24
52-week high
$2.41
52-week low
$1.55
50-day MA
$1.90
200-day MA
$1.91
Beta
1.59

Analyst view

Analysts rate Seer Inc a buy (1 buy, 2 hold, 0 sell out of 3) with an average price target of $4.00.

Shareholding

Insiders
14.37%
Institutions
50.66%

Largest institutional holders

FundStake
SoftBank Group Corp9.34%
Siren, L.L.C.4.47%
Acadian Asset Management LLC3.77%
Vanguard Capital Management, LLC3.56%
BlackRock Inc3.31%
Renaissance Technologies Corp1.78%
NANO CAP NEW MILLENNIUM GROWTH FUND L P1.50%
AJU IB Investment Co Ltd1.48%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Seer Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.